At the same time as researchers try to find biomarkers to predict ketamine response, clinicians find them selves with a conundrum: Which patients need to start with IV ketamine, and which with Spravato? And the way do The 2 compare head to head in precise response to treatment? This boost https://freemanq469ggd8.blog2freedom.com/profile